Appointed
(interim)
Constantine Nkafu
Interim Chief Executive Officer
CPMD ·
CANNAPHARMARX, INC.
The Board appointed Constantine Nkafu to serve as the Company’s interim CEO.
Ready 8-Ks
17
Latest filing
January 13, 2026, 6:59 PM ET
Top materiality
0.80
Event mix
other_material ×8 · leadership ×5 · m_and_a ×2
Sentiment
4 pos · 2 neg · 11 neu
Executive change
recent →
Recent 8-K filings for CPMD
Highest-materiality recent filing
CannaPharmaRX announces revocation of cease trade order by BC Securities Commission
- BC Securities Commission revoked failure-to-file cease trade order effective December 12, 2025.
- Company faces going concern uncertainty with working capital deficiency of $27,009,769 as of Sep 30, 2025.
-
CannaPharmaRX announces revocation of cease trade order by BC Securities Commission
BC Securities Commission revoked failure-to-file cease trade order effective December 12, 2025.
-
CannaPharmaRX completes first Germany shipment; 4 shipments to Israel done in 2024-2025
First Germany shipment in March 2025: 227.5 kg at avg. 1.94 CAD/gram; 4 Israel shipments totalling 664.4 kg through April 2025.
-
Auditor GreenGrowth CPAs resigns from CannaPharmaRX effective Nov 14, 2024
GreenGrowth CPAs resigned as auditor effective November 14, 2024.
-
CannaPharmaRX CEO Dean Medwid resigns for personal reasons; board searches for successor
Dean Medwid stepped down as CEO effective September 9, 2024, for personal reasons.
-
Agreement with Cantek, Israeli medical cannabis distributor, for minimum 1,000 kgs of product annually.
-
CannaPharmaRX acquires LTB Management for 33% stake, $3M notes, and warrants
Acquired all Class B interests in LTB Management; total consideration includes convertible preferred stock representing 33% of fully-diluted common (adjustable 28%-45% based on earn-out).
-
CannaPharmaRx signs LOI to acquire Oklahoma cannabis facility with $21M estimated annual revenue
Signed LOI to purchase 35,000 sq ft operating cannabis facility in Braman, OK; planned expansion to 65,000 sq ft by end of 2022.
Executive changes
Appointed
Elliot Zemel
Director
CPMD ·
CANNAPHARMARX, INC.
Messrs. Constantine Nkafu, Company’s interim CEO, and Elliot Zemel, have now been appointed to the Board.
Appointed
Constantine Nkafu
Director
CPMD ·
CANNAPHARMARX, INC.
Mr. Nkafu was also appointed to the Company’s Board
Departed
Dean Medwid
Chief Executive Officer
CPMD ·
CANNAPHARMARX, INC.
Dean Medwid stepped down as the Chief Executive Officer (“CEO”) of CannaPharmaRX, Inc. (the “Company”) for personal reasons.
Appointed
Oliver Foeste
Chief Financial Officer
CPMD ·
CANNAPHARMARX, INC.
Effective October 13, 2023, our Board of Directors has determined to appoint Oliver Foeste as Chief Financial Officer.
Departed
John Cassels
Chief Financial Officer
CPMD ·
CANNAPHARMARX, INC.
Effective October 13, 2023, John Cassels is being replaced as the Chief Financial Officer (“CFO”) of CannPharmaRX, Inc.
Departed
Mark Branson
Director
CPMD ·
CANNAPHARMARX, INC.
On March 23, 2023, Mark Branson informed the Board of Directors (the “Board”) of CannaPharmaRx, Inc. (the “Company”) that he intends to resign as a member of the Board effective immediately.
Appointed
Anthony Michael Panek
Director
CPMD ·
CANNAPHARMARX, INC.
On August 15th, 2023, the remaining members of the Board appointed Messrs. Adam Mindle and Anthony Michael Panek as members of the Board
Appointed
Adam Mindle
Director
CPMD ·
CANNAPHARMARX, INC.
On August 15th, 2023, the remaining members of the Board appointed Messrs. Adam Mindle and Anthony Michael Panek as members of the Board
Appointed
Dean Medwid
Chief Executive Officer
CPMD ·
CANNAPHARMARX, INC.
On June 1, 2023, the Company’s Board of Directors appointed Dean Medwid as Chief Executive Officer.
Departed
Dominic Colvin
Chief Executive Officer
CPMD ·
CANNAPHARMARX, INC.
Dominic Colvin stepped down as the Chief Executive Officer (“CEO”) of CannPharmaRX, Inc. (the “Company”) effective June 1, 2023.
Materiality & sentiment trend
Max materiality 0.80 · Median 0.55 · Most common event other_material